Research Topics
| S BellinoSummaryAffiliation: University of Turin Country: Italy Publications
| Collaborators |
Detail Information
Publications
Pharmacotherapy of borderline personality disorder: a systematic review for publication purposeS Bellino
Centre for Personality Disorders, Unit of Psychiatry 1, Department of Neurosciences, University of Turin, Via Cherasco 11, 10126 Turin, Italy
Curr Med Chem 18:3322-9. 2011..Effects of antidepressants on impulsive behaviours are uncertain. Further studies are needed to improve methods of trials and confirm these findings...
Quality of life of patients who undergo breast reconstruction after mastectomy: effects of personality characteristicsSilvio Bellino
Service for Personality Disorders, Unit of Psychiatry 1, Department of Neurosciences, University of Turin, Turin, Italy
Plast Reconstr Surg 127:10-7. 2011..The authors examined clinical and personality characteristics related to quality of life in patients receiving reconstructive surgery...
Adaptation of interpersonal psychotherapy to borderline personality disorder: a comparison of combined therapy and single pharmacotherapySilvio Bellino
Service for Personality Disorders, Unit of Psychiatry 1, Department of Neurosciences, University of Turin, Via Cherasco 11, Turin, Italy
Can J Psychiatry 55:74-81. 2010..The aim of our study is to investigate whether combined treatment with a modified version of IPT is still superior to ADs when treating patients with a single diagnosis of BPD...
Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorderSilvio Bellino
Service for Personality Disorders, Unit of Psychiatry, Department of Neurosciences, University of Turin, Via Cherasco 11, 10126 Torino, Italy
Psychiatry Res 161:206-12. 2008..Adverse effects were mild headache, insomnia, and anxiety. Aripiprazole is an efficacious and well-tolerated add-on treatment for sertraline-resistant BPD patients. It acts on impulsive and psychotic-like symptoms...
Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot studyS Bellino
Service for Personality Disorders, Unit of Psychiatry, Department of Neurosciences, University of Turin, Turin, Italy
J Psychopharmacol 24:333-9. 2010..Adverse effects were mild headache and nausea. Initial results suggest that duloxetine is an effective and well-tolerated treatment for BPD, with positive effects on somatic symptoms...
Efficacy and tolerability of pharmacotherapies for borderline personality disorderSilvio Bellino
Unit of Psychiatry, Department of Neurosciences, Service for Personality Disorders, University of Turin, Turin, Italy
CNS Drugs 22:671-92. 2008..Initial findings are encouraging for many of these drugs. However, data need to be replicated in further controlled studies with head-to-head comparisons and long-term follow-ups. Many questions remain to be answered...
Combined therapy of major depression with concomitant borderline personality disorder: comparison of interpersonal and cognitive psychotherapySilvio Bellino
Department of Neurosciences, University of Turin, Torino, Italy
Can J Psychiatry 52:718-25. 2007..We compare the effects of 2 combined therapies, fluoxetine and interpersonal therapy (IPT) or fluoxetine and cognitive therapy (CT), on major depression in patients with borderline personality disorder (BPD)...
Dysmorphic concern symptoms and personality disorders: a clinical investigation in patients seeking cosmetic surgerySilvio Bellino
Unit of Psychiatry, Department of Neuroscience, University of Turin, Via Cherasco 11, 10126 Torino, Italy
Psychiatry Res 144:73-8. 2006..Preoperative assessment could help to define the clinical profile of patients in cosmetic surgery settings...
Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot studySilvio Bellino
Unit of Psychiatry, Department of Neuroscience, University of Turin, Turin, Italy
J Clin Psychiatry 67:1042-6. 2006..Sparse data are available on the use of quetia-pine in treating this disorder. The aim of the present study is to investigate efficacy and tolerability of quetia-pine in a group of patients with borderline personality disorder...
Combined treatment of major depression in patients with borderline personality disorder: a comparison with pharmacotherapySilvio Bellino
Unit of Psychiatry, Department of Neuroscience, University of Turin, Torino, Italy
Can J Psychiatry 51:453-60. 2006..The aim of this study was to compare combined treatment using interpersonal psychotherapy (IPT) with pharmacotherapy alone in patients with depression and borderline personality disorder (BPD)...
Oxcarbazepine in the treatment of borderline personality disorder: a pilot studySilvio Bellino
Unit of Psychiatry, Department of Neuroscience, University of Turin, Turin, Italy
J Clin Psychiatry 66:1111-5. 2005..The present article is a pilot study on the efficacy and tolerability of oxcarbazepine in the treatment of borderline personality disorder...
Clinical picture of obsessive-compulsive disorder with poor insight: a regression modelSilvio Bellino
Unit of Psychiatry, Department of Neuroscience, University of Turin, Via Cherasco 11, 10126 Turin, Italy
Psychiatry Res 136:223-31. 2005..These results suggest that poor insight identifies a group of OCD patients with distinct clinical characteristics...
Major depression in patients with borderline personality disorder: a clinical investigationSilvio Bellino
Department of Neuroscience, University of Turin, Italy
Can J Psychiatry 50:234-8. 2005..This study aimed to compare the clinical characteristics of 2 groups of patients with MDD: those with concomitant BPD and those with other concomitant personality disorders...
Relationships of age at onset with clinical features and cognitive functions in a sample of schizophrenia patientsSilvio Bellino
Unit of Psychiatry, Department of Neuroscience, University of Turin, Turin, Italy
J Clin Psychiatry 65:908-14. 2004....
Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trialF Bogetto
Service for Depressive and Anxiety Disorders, Department of Neuroscience, University of Turin, Via Cherasco 11, 10126, Turin, Italy
Psychiatry Res 96:91-8. 2000..It appears that augmentation of olanzapine in fluvoxamine-refractory OCD may be effective in a large number of patients, including those with comorbid schizotypal personality disorder...
Recognition and treatment of dysthymia in elderly patientsS Bellino
Department of Neuroscience, Psychiatric Unit, University of Turin, Torino, Italy
Drugs Aging 16:107-21. 2000..All these topics need to be further investigated in studies comparing the elderly with control groups of younger patients with dysthymia...
Depressive and negative symptoms in schizophrenia: different effects on clinical featuresPaola Rocca
Department of Neuroscience, Unit of Psychiatry, University of Turin, 10126 Torino, Italy
Compr Psychiatry 46:304-10. 2005..We also analyzed whether depressive and negative symptoms presented different patterns of predictors...
Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigationFilippo Bogetto
Unit of Psychiatry, Department of Neuroscience, University of Turin, Turin, Italy
CNS Drugs 16:273-83. 2002..The syndrome is related both to drug and clinical characteristics. The features of the syndrome in patients with different Axis I diagnoses should be compared in further investigations...
Clinical features of dysthymia and age: a clinical investigationS Bellino
Depressive and Anxiety Disorders Unit, Department of Neuroscience, University of Turin, Via Cherasco 11, 10126, Turin, Italy
Psychiatry Res 103:219-28. 2001..The data suggested different etiologic pathways in older and younger patients. Dysthymia appeared to be associated in younger adults with abnormalities of personality; in the elderly, with a history of health problems and life losses...
